785960005: Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release orodispersible tablet (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing dihydroxyphenylalanine decarboxylase inhibitor (product)\Product containing carbidopa (medicinal product)\Product containing carbidopa in oral dose form (medicinal product form)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing dihydroxyphenylalanine decarboxylase inhibitor (product)\Product containing carbidopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Product containing only carbidopa and levodopa (medicinal product)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing dihydroxyphenylalanine decarboxylase inhibitor (product)\Product containing carbidopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
\Medicinal product categorized by disposition (product)\Product containing dopamine receptor agonist (product)\Product containing carbidopa (medicinal product)\Product containing carbidopa in oral dose form (medicinal product form)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
\Medicinal product categorized by disposition (product)\Product containing dopamine receptor agonist (product)\Product containing carbidopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Product containing only carbidopa and levodopa (medicinal product)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
\Medicinal product categorized by disposition (product)\Product containing dopamine receptor agonist (product)\Product containing carbidopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
\Medicinal product categorized by disposition (product)\Product containing dopamine receptor agonist (product)\Product containing levodopa (medicinal product)\Product containing levodopa in oral dose form (medicinal product form)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
\Medicinal product categorized by disposition (product)\Product containing dopamine receptor agonist (product)\Product containing levodopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Product containing only carbidopa and levodopa (medicinal product)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
\Medicinal product categorized by disposition (product)\Product containing dopamine receptor agonist (product)\Product containing levodopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet

\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing catecholamine (product)\...

\Product containing carbidopa (medicinal product)\Product containing carbidopa in oral dose form (medicinal product form)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
\Product containing carbidopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Product containing only carbidopa and levodopa (medicinal product)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
\Product containing carbidopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet

\Product containing levodopa (medicinal product)\Product containing levodopa in oral dose form (medicinal product form)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
\Product containing levodopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Product containing only carbidopa and levodopa (medicinal product)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
\Product containing levodopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet

\Product manufactured as oral dose form (product)\Product containing levodopa in oral dose form (medicinal product form)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
\Product manufactured as oral dose form (product)\Product containing carbidopa in oral dose form (medicinal product form)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3769839012 Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3769840014 Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release orodispersible tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	Has presentation strength numerator value	250	false	Inferred relationship	Some	1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	Has unit of presentation	Tablet (unit of presentation)	true	Inferred relationship	Some
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	Has presentation strength numerator value	25	false	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Levodopa (substance)	true	Inferred relationship	Some	1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	Has manufactured dose form	Orodispersible tablet	true	Inferred relationship	Some
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	Has presentation strength denominator value	un	false	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	This attribute specifies the numerator unit for the presentation strength of a product.	mg	true	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	This attribute specifies the denominator unit for the presentation strength of a product.	Tablet (unit of presentation)	true	Inferred relationship	Some	1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	Has presentation strength denominator value	un	false	Inferred relationship	Some	1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Carbidopa anhydrous	true	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	This attribute specifies the numerator unit for the presentation strength of a product.	mg	true	Inferred relationship	Some	1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	Count of base of active ingredient	deux	false	Inferred relationship	Some
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Carbidopa	true	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Levodopa (substance)	true	Inferred relationship	Some	1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	This attribute specifies the denominator unit for the presentation strength of a product.	Tablet (unit of presentation)	true	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	Is a	Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form)	false	Inferred relationship	Some
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	Plays role	Antiparkinson therapeutic role	false	Inferred relationship	Some
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	Is a	Product containing only carbidopa and levodopa in oral dose form (medicinal product form)	true	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3769839012	Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3769840014	Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release orodispersible tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core